Plain-English translation of NCT07231471 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing Platelet Rich Plasma (PRP)—an injection made from your own blood—as a treatment for pain and stiffness in joints and muscles. Researchers believe PRP may work better than current standard treatments like steroid injections, with fewer side effects. The trial will measure whether PRP reduces your pain, improves how well your joints work, and how satisfied you are with the treatment.
Many people with arthritis and other joint problems don't get enough relief from current treatments like steroid injections, which can have risks with long-term use. This medication uses your body's own healing cells and may offer a safer, more effective option for managing musculoskeletal pain.
You likely qualify if…
You likely don't qualify if…
You will receive a single PRP injection in the affected joint or area. A small blood sample will be drawn and processed to create the injection, which is then administered. You'll be asked to complete follow-up surveys at 2 weeks, 6 weeks, 3 months, 6 months, and 12 months after your injection to track your pain levels, how well your joint is functioning, and your overall satisfaction with the treatment.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
United States